Strategy involves placing targets on deadly cancer’s cells, potentially making them vulnerable to immunotherapies By: Julia Evangelou Strait Even treated with the most advanced therapies, patients with glioblastoma — an aggressive brain cancer — typically survive less than two years after diagnosis. Efforts to treat this cancer with the latest immunotherapies have been unsuccessful, likely […]
Researchers make glioblastoma cells visible to attacking immune cells
